Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

US Post-Market Surveillance Study of the Surfacer System

NCT: NCT05050799 · RECRUITING

NCT IDNCT05050799
StatusRECRUITING
Start Date2022-02-08
Completion2026-12-15
SponsorMerit Medical Systems, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

Single arm, observational, multi-center, consecutively enrolling, post-market surveillance study. Treating patients in need of central venous access who have upper body venous occlusions or other conditions that preclude central venous access by conventional methods, and who meet the requirements described in the device labeling.

Frequently Asked Questions

What is US Post-Market Surveillance Study of the Surfacer System?

US Post-Market Surveillance Study of the Surfacer System is a clinical trial registered under NCT05050799. Current status: RECRUITING.

What is the status of NCT05050799?

The current status of NCT05050799 (US Post-Market Surveillance Study of the Surfacer System) is: RECRUITING.

When did US Post-Market Surveillance Study of the Surfacer System start?

US Post-Market Surveillance Study of the Surfacer System started on 2022-02-08.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.